PHAR
Asset Logo

Pharming Group NV

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-12.30%
Annual Growth

4 years average annual growth

🌏

0
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

πŸ“ˆ Performance

Price History*

-47.60%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$8.34

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in PHAR

0

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

N/A

πŸ’΅ Average investment amount

N/A

⏰ Last time a customer invested in PHAR

12 days
PHAR investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

πŸ™‹ Legal gender of investors

Female

Male

Pearlers who invest in PHAR also invest in...

Global X Robotics & Artificial Intelligence ETF

BOTZ

πŸ™Œ Performance (5Yr p.a)

9.68%

πŸ“Š Share price

$32.11 USD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

πŸ™Œ Performance (5Yr p.a)

8.57%

πŸ“Š Share price

$117.65 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

9.36%

πŸ“Š Share price

$37.54 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

43.40%

πŸ“Š Share price

$53.54 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

9.13%

πŸ“Š Share price

$175.18 USD

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

-5.68%

πŸ“Š Share price

$18.95 USD

πŸ™Œ Performance (5Yr p.a)

44.22%

πŸ“Š Share price

$638.00 USD

πŸ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist